Tubulointerstitial nephritis New

Tubulointerstitial nephritis (TIN) is a heterogeneous group of kidney diseases characterized by inflammation and injury of the renal tubules and interstitium, with relative sparing of the glomeruli.  

It represents an important cause of acute kidney injury (AKI) and may progress to chronic kidney disease (CKD) if untreated.  

Classification of TIN

Classification
According to duration
  • Acute tubulointerstitial nephritis (ATIN)
    • Sudden onset
    • Often reversible
  • Chronic tubulointerstitial nephritis (CTIN)
    • Gradual progression
    • Leads to fibrosis and irreversible damage
According to etiology
  • Drug-induced (most common)
  • Infectious
  • Autoimmune/systemic
  • Metabolic/toxic
  • Idiopathic


Characteristics of TIN

Tubular dysfunction may also lead to:

  • impaired urine concentrating ability
  • electrolyte disturbances (e.g., acidosis, potassium imbalance)

Acute TIN

Acute forms are characterized by rapid onset of renal dysfunction associated with inflammatory infiltration of the interstitium. includes:

  • Acute bacterial TIN
  • Acute hypersensitivity (drug-induced) TIN
  • Parainfectious TIN
  • Idiopathic forms

Acute bacterial TIN

Most commonly arises from ascending urinary tract infection. Predisposing factors:

Clinical presentation

  • Fever and systemic inflammatory signs
  • Flank or lumbar pain
  • Dysuria and urinary frequency
  • Possible oliguria

Examination

Physical findings:

  • shortness of breath, sweating, febrile illness, often accompanied by chills
  • active occupation of the relief position
  • positive tapottement

Urinalysis:

  • leukocyturia (constant)
  • bacteriuria should also always be present. If the detection of bacteria fails, the possibility of TB infection must be considered
  • non-glomerular erythrocyturia
  • proteinuria usually <2 g/day

Laboratory tests:

Microbiology:

  • urine culture mandatory (commonly E. coli, Klebsiella)

Imaging:

Renal biopsy is generally not required in typical cases.

Therapy

  • Empirical antibiotics → adjusted according to culture
  • Common regimens include cephalosporins, aminoglycosides, fluoroquinolones
  • Treatment duration: usually ≥2 weeks

Acute hypersensitivity TIN

This form is typically drug-induced (e.g., antibiotics, NSAIDs).

Pathogenesis

Immune-mediated reaction with interstitial infiltration by lymphocytes and eosinophils.

Clinical features

  • Fever
  • Skin rash
  • Arthralgia
  • Renal dysfunction

Latency of 1–6 weeks after drug exposure is typical.

Examination

Urine findings

Blood tests

Biopsy

  • interstitial inflammation ± granulomas

Therapy

  • Immediate withdrawal of the causative drug
  • Corticosteroids if renal function does not improve

Chronic TIN

Chronic forms are characterized by progressive interstitial fibrosis and tubular atrophy, leading to irreversible renal damage. Main types:

  • Chronic bacterial TIN
  • Reflux nephropathy
  • Analgesic nephropathy
  • Toxic/metabolic nephropathies

Chronic bacterial TIN

Usually develops after recurrent acute infections.

Clinical features

  • often asymptomatic between episodes
  • gradual decline in renal function

Findings

Therapy

  • treatment of acute exacerbations
  • long-term prevention in recurrent cases

Reflux nephropathy

Associated with vesicoureteral reflux (VUR) leading to repeated renal injury.

Pathogenesis

Retrograde urine flow → recurrent infections → scarring.

Clinical features

  • recurrent UTIs (especially in childhood)
  • enuresis in children
  • later: hypertension, renal insufficiency

Diagnosis

  • urine abnormalities (leukocyturia, bacteriuria)
  • imaging (voiding cystography, scintigraphy)

Therapy

  • management of infections
  • surgical correction of reflux
  • treatment of CKD complications

Analgesic nephropathy

Results from chronic abuse of analgesics (historically phenacetin-containing drugs).

Features

  • slowly progressive renal insufficiency
  • hematuria
  • renal colic (papillary necrosis)
  • hypertension

Complications

  • increased risk of urothelial carcinoma
  • other manifestations (psychosomatic, bone, cardiovascular, hematological and gastrointestinal disorders).

Refrences

External sources